Sai Sheng Pharmaceutical (300485.SZ) received a notification letter for the registration acceptance of Nalmefene hydrochloride injection drug.

The Zhitong Finance APP reports that Saisheng Pharmaceutical (300485.SZ) has issued an announcement, stating that the company recently received a drug registration acceptance notification for injection of Nefopam Hydrochloride from the National Medical Products Administration.